Ergoteles’s Carter's CRI Stock Holding History

Ergoteles’s Portfolio CRI Stock Details CRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-14,431	Closed	-$1.05M	–	223
2023 Q2	$1.05M	Buy	+14,431	New	+$975K	0.05%	452

Other funds holding CRI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Ergoteles's CRI Position: Q3 2023 in Review

Ergoteles sold out of Carter's (CRI) in Q3 2023, closing a stake of 14,431 shares — an estimated $1.05M sold.

Ergoteles first reported a position in CRI in Q2 2023 and held it in 1 quarter. The position peaked at $1.05M in Q2 2023. 301 funds tracked by Wall St. Rank hold CRI as of Q3 2023.

Ergoteles reported no remaining Carter's position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 14,431 Carter's shares in Q3 2023, an estimated $1.05M.
Ergoteles first reported a position in Carter's in Q2 2023 and held it in 1 quarter.
Ergoteles's Carter's position peaked at $1.05M in Q2 2023.
301 funds tracked by Wall St. Rank held Carter's as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.